Bionomics to conduct trials on anti-cancer drug – Sydney Morning Herald
Proactive Investors Australia Bionomics to conduct trials on anti-cancer drug Sydney Morning Herald Junior biotechnology company Bionomics will conduct a Phase II clinical trial of its BNC105 anti-cancer drug on 60 mesothelioma patients at up to 12 centres … Bionomics mesothelioma trials BigPond News Bionomics to conduct Phase II clinical trial on its BNC105 anti-cancer drug Proactive Investors Australia all 8 news articles
